HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Pai, R. G. Articles by Varadarajan, P. Search for Related Content PubMed PubMed Citation Articles by Pai, R. G. Articles by Varadarajan, P. Related Collections Valve disease Related Article

Ann Thorac Surg 2006;82:2116-2122
© 2006 The Society of Thoracic Surgeons

---

Original Articles: Cardiovascular

Malignant Natural History of Asymptomatic Severe Aortic Stenosis: Benefit of Aortic Valve Replacement

Division of Cardiology, Loma Linda University Medical Center, Loma Linda, California

Accepted for publication July 11, 2006.

^_* Address correspondence to Dr Pai, Division of Cardiology, USC/Keck School of Medicine, 1510 San Pablo Street, Suite 322, Los Angeles, CA 90033. (Email: rpai{at}usc.edu).

BACKGROUND: Patients with asymptomatic severe aortic stenosis (AS) are reported to have a benign prognosis and hence the American College of Cardiology/American Heart Association guidelines do not recommend aortic valve replacement (AVR) for patients with isolated asymptomatic severe AS. However, symptoms are subjective and would depend upon patient’s life style. We examined the natural and unnatural history of initially asymptomatic patients with severe AS.

METHODS: A search of our echocardiographic database between 1993 and 2003 yielded 740 patients with severe AS defined as aortic valve area 0.8 cm² or less. Thorough chart reviews were conducted to collect clinical and pharmacologic data. Of these, 338 patients were asymptomatic at the initial encounter forming the study cohort.

RESULTS: Patient characteristics were the following: age 71 ± 15 years, males 51%, aortic valve area 0.72 ± 0.17 cm², left ventricular ejection fraction 0.59 ± 0.17. Ninety-nine (29%) patients had AVR during a mean follow-up of 3.5 years. Survival at 1, 2, and 5 years in the nonoperated patients were 67%, 56%, and 38%, respectively, compared with 94%, 93%, and 90% in those who underwent AVR (p < 0.0001). The Cox regression model was used to adjust for the effect of 18 clinical, echocardiographic, and pharmacologic variables on survival. The adjusted hazard ratio for death with AVR was 0.17 (95% confidence interval [CI] 0.10 to 0.29). In the nonoperated group, renal insufficiency (risk ratio [RR] 3.1, 95% CI 1.5 to 6.6), beta blocker use (RR 0.52, 95% CI 0.31 to 0.88), statin use (RR 0.52, 95% CI 0.27 to 0.99), age (per year RR 1.03, 95% CI 1.02 to 1.05), and left ventricular ejection fraction (per % RR 0.99, 95% CI 0.98 to 1.00) were found to be the independent predictors of mortality. The benefit of AVR was further supported by sensitivity and propensity score analyses.

CONCLUSIONS: Our observational data indicate that the natural history of asymptomatic AS is not benign and that survival is dramatically improved by AVR. Survival of the asymptomatic unoperated or nonoperable patients may potentially be improved by the use of beta blockers and statins.

Related Article

Clinical Profile and Natural History of 453 Nonsurgically Managed Patients With Severe Aortic Stenosis

Padmini Varadarajan, Nikhil Kapoor, Ramesh C. Bansal, and Ramdas G. Pai
Ann. Thorac. Surg. 2006 82: 2111-2115. [Abstract] [Full Text] [PDF]

This article has been cited by other articles:

				L. G. Svensson, T. Dewey, S. Kapadia, E. E. Roselli, A. Stewart, M. Williams, W. N. Anderson, D. Brown, M. Leon, B. Lytle, et al. United States feasibility study of transcatheter insertion of a stented aortic valve by the left ventricular apex. Ann. Thorac. Surg., July 1, 2008; 86(1): 46 - 55. [Abstract] [Full Text] [PDF]

				M. L. Brown, P. A. Pellikka, H. V. Schaff, C. G. Scott, C. J. Mullany, T. M. Sundt, J. A. Dearani, R. C. Daly, and T. A. Orszulak The benefits of early valve replacement in asymptomatic patients with severe aortic stenosis. J. Thorac. Cardiovasc. Surg., February 1, 2008; 135(2): 308 - 315. [Abstract] [Full Text] [PDF]

				R. G. Pai, P. Varadarajan, N. Kapoor, and R. C. Bansal Aortic Valve Replacement Improves Survival in Severe Aortic Stenosis Associated With Severe Pulmonary Hypertension Ann. Thorac. Surg., July 1, 2007; 84(1): 80 - 85. [Abstract] [Full Text] [PDF]

				R. G. Pai and P. Varadarajan Reply. Ann. Thorac. Surg., July 1, 2007; 84(1): 356 - 357. [Full Text] [PDF]

				A. Cannata, P. Fratto, and E. Vitali Asymptomatic Aortic Valve Stenosis: To Operate or Not to Operate? Ann. Thorac. Surg., July 1, 2007; 84(1): 355 - 356. [Full Text] [PDF]